Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs Boundless (ZKC) Price & Performance

InjectiveTrade
BoundlessTrade

Price performance (Past 24H)

Key statistics

Injective vs Boundless — how do they compare? Injective trades at Rp92,347 (market cap Rp9,23T, Rp1,78T 24h volume), while Boundless trades at Rp779.44 (market cap Rp239,61M, Rp76,53M 24h volume). The key difference: Injective is far larger — about 38520.9× Boundless's market cap, and Injective's circulating supply is 100M INJ versus 307,6M ZKC for Boundless. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Boundless for 13 Days on average.

INJZKC
Market Cap
Rp9,23TRp239,61M
Volume (24h)
Rp1,78TRp76,53M
Circulating Supply
100M INJ307,6M ZKC
Typical Hold Time
36 Days13 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Boundless

Boundless (ZKC) trades at Rp785.53 with a market cap of Rp241.84 million, showing a bearish technical signal with moving averages indicating selling pressure while oscillators remain neutral. The token faces resistance at Rp837 and finds support at Rp769, with current price action constrained within this range. No recent protocol updates or significant ecosystem developments have been reported.

Overall outlook remains cautious due to bearish technical indicators and limited fundamental catalysts. Key opportunities include potential bounce from support levels, while major risks involve low market cap volatility and lack of recent development activity. Investors should monitor for any protocol updates or exchange listing developments.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
29% Buy71% Sell
Avg holding period · 36 Days
ZKC
10% Buy90% Sell
Avg holding period · 13 Days

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About Boundless

Boundless is a universal protocol designed to empower every blockchain with the capabilities of zero-knowledge (ZK) technology. It allows independent prover nodes to generate ZK proofs for layer 1 blockchains, applications, rollups, and infrastructure across all chains. By offloading computation to the Boundless network and verifying proofs on-chain, Boundless offers a consistent layer for scalability and interoperability, all without requiring changes to existing networks.

Read more on ZKC